1-4 of 4
Yan Geng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Factor XI Monoclonal Antibody SHR-2004 in Healthy Subjects

Tingting Ma, Bei Cao, Zuyi Weng, Yanli Dong, Shimin An, Lei Huang, Yuanxun Yang, Yan Geng, Hui Lin, Yuqi Wang, Pinhao Xie, Kai Shen, Juan Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 3981.
https://doi.org/10.1182/blood-2023-173295
Published: 2023
Journal Articles

Inhibition of LDHA to induce eEF2 release enhances thrombocytopoiesis

Qidi Chen, Min Xin, Lingjun Wang, Lin Li, Yingzhi Shen, Yan Geng, Haojie Jiang, Yang Wang, Lin Zhang, Yanyan Xu, Yu Hou, Junling Liu, Xuemei Fan
Journal: Blood
Blood (2022) 139 (19): 2958–2971.
https://doi.org/10.1182/blood.2022015620
Published: 2022
Includes: Supplemental data
Journal Articles

Long-Term Follow-up of a Phase 1, First-in-Human Open-Label Study of LCAR-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (BCMA), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Bai-Yan Wang, MD PhD, Wan-Hong Zhao, MD PhD, Jie Liu, MD, Yin-Xia Chen, MD, Xing-Mei Cao, MD, Yun Yang, MD, Yi-Lin Zhang, MD, Fang-Xia Wang, MD PhD, Peng-Yu Zhang, MD PhD, Bo Lei, MD, Liu-Fang Gu, MD PhD, Jian-Li Wang, MD PhD, Jia-Jia Zhang, MD, Ru Zhang, MD, Hui Zhang, MD, Ying Shen, MD, Ju Bai, PhD, Yan Xu, MD, Xu-Geng Wang, MD PhD, Rui-Li Zhang, MD, Li-Li Wei, MD, Zong-Fang Li, MD PhD, Gai-Xia He, PhD, Yan Geng, MD PhD, Qian He, MD PhD, Qiu-Chuan Zhuang, Msc, Frank Xiao-Hu Fan, MD PhD, Wang-Gang Zhang, MD PhD, Ai-Li He, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 579.
https://doi.org/10.1182/blood-2019-124953
Published: 2019
Journal Articles

Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma

Wan-Hong Zhao, MD PhD, Jie Liu, MD, Bai-Yan Wang, MD PhD, Yin-Xia Chen, MD, Xing-Mei Cao, MD, Yun Yang, MD, Yi-Lin Zhang, MD, Fang-Xia Wang, MD PhD, Peng-Yu Zhang, MD PhD, Bo Lei, MD, Liu-Fang Gu, MD PhD, Jian-Li Wang, MD PhD, Nan Yang, MD, Ru Zhang, MD, Hui Zhang, MD, Ying Shen, MD, Ju Bai, PhD, Yan Xu, Xu-Geng Wang, MD PhD, Rui-Li Zhang, MD, Li-Li Wei, MD, Zong-Fang Li, MD PhD, Zhen-Zhen Li, PhD, Yan Geng, MD PhD, Qian He, MD PhD, Qiu-Chuan Zhuang, Msc, Frank Xiao-Hu Fan, MD PhD, Ai-Li He, MD PhD, Wang-Gang Zhang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 955.
https://doi.org/10.1182/blood-2018-99-110548
Published: 2018